Atlas Trials

Safety and Efficacy of Bexagliflozin in Type 2 Diabetes Mellitus Patients With Moderate Renal Impairment

Clinical trial NCT02836873 · COMPLETED

Trial details

NCT number
NCT02836873
Sponsor
Theracos
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Type 2 Diabetes Mellitus
Start date
2016-09-23
Primary completion
2018-01-11
Enrollment
312

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.